MENU
RGTLF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Argent BioPharma (RGTLF) Ownership - Who owns Argent BioPharma?
Argent Biopharma Ltd is a clinical-stage biopharmaceutical company pioneering nano-engineered therapeutics that reset the balance between the nervous and immune systems... Show more
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
4.45M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
301.04K
Risk (Beta)
-2.82
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
RGTLF
Capitalization
4.45M
P/E Ratio
N/A
Risk (Beta)
-2.82
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
301K
ROE
N/A
Book Value
N/A
P/B Ratio
12.30
Cash Flow
N/A
Earnings
-0.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
0.19
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.44M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-221.81
Shares Held By Institutions
0
Shares Outstanding - Current
77.8M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
-25.026
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information